Besides its anti-apoptotic role, NFκB represents a key link between inflammation and cancer (see [43] for review), and in particular, is considered a master regulator of intestinal immunological function and activator of factors involved in driving intestinal inflammation [44-46]. Here, NFKB1 is linked to cancer.